Response to Platinum-Based Chemotherapy Predicts Survival in Lung Cancer Patients. Prospective Analysis of 340 Patients.

被引:0
|
作者
Duarte, R. L. M.
Paschoal, M. E. M.
机构
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4440
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Early response to platinum-based chemotherapy in non small cell lung cancer (NSCLC) predicts survival unluike in mesotheliomas
    Sirohi, B
    Matakidou, A
    Benson, C
    Ashley, S
    Priest, K
    Norton, A
    James, M
    Saka, W
    Popat, S
    O'Brien, M
    LUNG CANCER, 2005, 49 : S91 - S91
  • [12] Chemotherapy-induced amenorrhea (CIA) risk associated with taxane/platinum-based chemotherapy in young (≤45 years) breast cancer patients.
    Sharma, Priyanka
    Rock, Lindsay
    Kimler, Bruce F.
    Khan, Qamar J.
    Connor, Carol Sue
    McGinness, Marilee
    Wagner, Jamie Lynn
    Mammen, Joshua
    Ward, Claire
    Klemp, Jennifer R.
    Fabian, Carol J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [13] Cetuximab plus platinum-based chemotherapy improves survival for patients with newly diagnosed advanced lung cancer
    不详
    ONCOLOGY-NEW YORK, 2008, 22 (07): : 800 - +
  • [14] The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non-Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy
    Jia, Ming
    Xu, Yuan
    Zhu, Meiling
    Wang, Mengyun
    Sun, Menghong
    Qian, Ji
    Chang, Jianhua
    Wei, Qingyi
    TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 531 - 539
  • [15] Demographical differentials of lung cancer survival in Bangladeshi patients.
    Islam, Muhammad Rafiqul
    Hasan, Atm Kamrul
    Begum, Ferdous Ara
    Khatun, Nazrina
    Islam, Md. Rafiqul
    Zaman, Asaduz
    Arjuman, Farida
    Ridi, Ishrat Nur
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [16] ERCC1 expression predicts treatment response and survival in advanced uterine cervical cancer patients treated with platinum-based chemotherapy
    Baek, S. W.
    Choi, Y. S.
    Song, I. C.
    Yun, H. J.
    Jo, D. Y.
    Kim, S. Y.
    Lee, H. J.
    ANNALS OF ONCOLOGY, 2015, 26 : 81 - 82
  • [17] ERCC1 and TOPOIIa mRNA levels predict response to platinum/etoposide chemotherapy and survival of small-cell lung cancer patients.
    Giovanni, Selvaggi
    Paolo, Ceppi
    Giai, Levra Matteo
    Novello, Silvia
    Longo, Marina
    Cappia, Susanna
    Papotti, Mauro
    Volante, Marco
    Scagliotti, Giorgio, V
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S425 - S425
  • [18] Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy
    Ioannidis, Georgios
    Souglakos, John
    Georgoulias, Vassilis
    LUNG CANCER MANAGEMENT, 2013, 2 (04) : 281 - 293
  • [19] Weight Loss Associated with Platinum-Based Chemotherapy in Patients with Advanced Lung Cancer
    Morio, Kayoko
    Minami, Toshiyuki
    Sozu, Takashi
    Niki, Kazuyuki
    Kijima, Takashi
    Uejima, Etsuko
    CHEMOTHERAPY, 2015, 61 (05) : 256 - 261
  • [20] Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
    Liu, Jia-Si
    Liu, Jun-Yan
    Xiao, Qi
    Li, Xiang-Ping
    Chen, Juan
    Liu, Zhao-Qian
    FRONTIERS IN PHARMACOLOGY, 2023, 14